The addition of sodium hydroxide to an ethanolic dehydro-l-ascorbic acid solution produced a yellowish precipitate which was enriched by a reductant possessing absorption maxima at 345 and 225 nm. This reductant was purified by DEAE-Sepharose column chromatography and Cellulofine-gel chromatography; on the basis of physicochemical analyses it was deduced to be the 2,3-enediol form of 2,3-diketo-l-gulono-δ-lactone (2,3,6-trihydroxy-4-oxo-2-hexen-5-olide). The process, derived from dehydro-l-ascorbic acid, involved a hydrolytic cleavage of a 5-membered γ-lactone ring, conversion to the 2,3-enediol form and rearrangement to 6-membered δ-lactone. The marked bathochromic shift of the absorption maximum of this reductant from that of ascorbic acid (265 nm) could be due to an extended conjugation among the enediol group and two carbonyl groups on both sides.
将
氢氧化钠加入
乙醇脱氢抗坏血酸溶液中,生成了一种黄色沉淀物,该沉淀物经具有345和225 nm吸收峰的还原剂富集。该还原剂通过
DEAE-Sepharose柱色谱和Cellulofine-gel色谱法纯化;基于物理
化学分析,推断其为
2,3-二酮-L-古洛糖酸-δ-内酯的2,3-烯二醇形式(2,3,6-三羟基-4-氧代-
2-己烯-
5-内酯)。该过程源自
脱氢抗坏血酸,涉及一个五元γ-内酯环的
水解断裂,转化为2,3-烯二醇形式,并重排为六元δ-内酯。该还原剂的最大吸收峰与
抗坏血酸(265 nm)相比显著红移,可能是由于烯二醇基团与两侧的两个羰基之间的共轭延伸所致。